Introduction
The drug with the NDC code 0228-3059 is an extended-release capsule formulation of a combination of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. This medication is primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD)[1].
Current Market Context
The pharmaceutical market, particularly for prescription drugs, is experiencing significant price fluctuations. Here are some key points to consider:
- Price Increases: From January 2022 to January 2023, over 4,200 drug products saw price increases, with an average increase of 15.2% or $590 per drug product. This trend indicates that drug prices are rising at a rate higher than inflation[2].
- Specialty Pharmaceuticals: The segment of specialty pharmaceuticals, which includes drugs for complex or chronic conditions, is driving a significant portion of the price increases. These drugs, including those for ADHD, are expected to continue influencing overall drug price inflation[4].
Specific Drug Pricing Trends
Historical Price Changes
The drug NDC 0228-3059, being a prescription medication, is subject to the broader trends in pharmaceutical pricing. While specific historical price data for this NDC is not provided, the general trend suggests that prescription drugs, especially those in the specialty category, have seen substantial price increases in recent years[2].
Projected Price Increases
For 2024 and 2025, Vizient Inc. projects a 3.8% increase in drug prices, driven largely by specialty pharmaceuticals. This projection includes an anticipated 4.18% increase for specialty medications, which could impact the pricing of ADHD medications like the one with NDC 0228-3059[4].
Factors Influencing Price Projections
Regulatory and Market Dynamics
- Drug Shortages and Supply Chain: Managing pharmacy expenditures and strengthening the supply chain are critical due to drug shortages and rising costs. This could impact the pricing stability of specific drugs[4].
- Biosimilars and Generic Competition: Although biosimilars are expected to grow in market share, their impact on the pricing of branded ADHD medications might be limited until they are more widely adopted and mandated by payers[4].
Economic Factors
- Inflation and Economic Conditions: The average price increase for prescription drugs has been higher than the rate of inflation, suggesting that economic conditions are contributing to the rising costs of medications[2].
Expert Insights and Future Trends
Adoption of AI and Data Analytics
The pharmaceutical industry is increasingly adopting artificial intelligence (AI) and external data to improve drug development and pricing strategies. This could lead to more precise pricing models and better market forecasting, potentially stabilizing or influencing the prices of specific drugs[3].
Specialty Pharmacy Growth
The growth in specialty pharmacy, including weight loss drugs and gene therapies, is expected to drive higher drug costs. This segment's expansion could further increase the overall spend on prescription medications, including those for ADHD[4].
Key Takeaways
- Price Increases: Prescription drugs, including ADHD medications, are experiencing significant price increases, often exceeding the rate of inflation.
- Specialty Pharmaceuticals: The segment of specialty pharmaceuticals is a major driver of these price increases.
- Market Projections: A 3.8% increase in drug prices is projected for 2024-2025, with specialty medications expected to see a 4.18% increase.
- Regulatory and Market Dynamics: Factors such as drug shortages, supply chain issues, and the adoption of biosimilars will continue to influence drug pricing.
FAQs
-
What is the primary use of the drug with NDC 0228-3059?
- The primary use of this drug is to treat Attention Deficit Hyperactivity Disorder (ADHD)[1].
-
What is the projected increase in drug prices for 2024-2025?
- Vizient Inc. projects a 3.8% increase in drug prices, driven largely by specialty pharmaceuticals[4].
-
How do biosimilars impact the pricing of branded ADHD medications?
- Biosimilars are expected to grow in market share, but their immediate impact on branded ADHD medication prices may be limited until they are more widely adopted and mandated by payers[4].
-
What role does AI play in the pharmaceutical industry's pricing strategies?
- AI is increasingly used to improve drug development and pricing strategies, potentially leading to more precise pricing models and better market forecasting[3].
-
What are the economic factors influencing the prices of prescription drugs?
- Economic factors such as inflation and the overall economic conditions contribute to the rising costs of medications, with price increases often exceeding the rate of inflation[2].
Sources
- DailyMed - DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE capsule, extended release
- ASPE - Changes in the List Prices of Prescription Drugs, 2017-2023
- Intelligencia.ai - 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch
- Vizient Inc. - Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
